ZEALAND PHARMA A/S
CVR 20045078 · Public limited company (A/S) · Active · Low risk
ZEALAND PHARMA A/S is a Public limited company (A/S), founded on , based in Søborg. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. Our model estimates a bankruptcy risk of 0.4% over the next 12 months, which is 0.3 times the average for Danish companies. 20 annual reports have been published. CEO: Henriette Wennicke.
Bankruptcy risk for ZEALAND PHARMA A/S
0.3 × the average (1.41%) · higher risk than 58% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 20045078
- Status
- Active
- Company type
- Public limited company (A/S)
- Founded
- (29 years)
- Address
- Sydmarken 11
2860 Søborg - Municipality
- Gladsaxe
- Industry
- Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik - Share capital
- DKK 71.6m
- Employees
- 153 (2018)
- Auditor
- PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB
- Audit opted out
- No
Warning signs
| Annual reports filed late | 1 of 28 |
| Missing annual report | No |
| Negative equity | – |
| Equity ratio | – |
| Current ratio | – |
| Moves (last 2 years) | 0 |
| CEO changes in total | 16 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 3 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2026 | 2025 | 2025 | 2024 |
|---|
Latest annual report: Reporting class D · auditor's statement: No audit assistance.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 86 | ||
| 1 Jan 2024 – 31 Dec 2024 | 94 | ||
| 1 Jan 2023 – 31 Dec 2023 | 81 | ||
| 1 Jan 2022 – 31 Dec 2022 | 93 | ||
| 1 Jan 2021 – 31 Dec 2021 | 124 | ||
| 1 Jan 2020 – 31 Dec 2020 | 111 | ||
| 1 Jan 2019 – 31 Dec 2019 | 99 | ||
| 1 Jan 2018 – 31 Dec 2018 | 119 | ||
| 1 Jan 2017 – 31 Dec 2017 | 110 | ||
| 1 Jan 2016 – 31 Dec 2016 | 101 | ||
| 1 Jan 2015 – 31 Dec 2015 | 117 | ||
| 1 Jan 2014 – 31 Dec 2014 | 116 | ||
| 1 Jan 2013 – 31 Dec 2013 | 168 | ||
| 1 Jan 2012 – 31 Dec 2012 | 141 | ||
| 1 Jan 2011 – 31 Dec 2011 | 120 | ||
| 1 Jan 2010 – 31 Dec 2010 | 125 | ||
| 1 Jan 2009 – 31 Dec 2009 | 125 | ||
| 1 Jan 2008 – 31 Dec 2008 | 124 | ||
| 1 Jan 2007 – 31 Dec 2007 | 175 | ||
| 1 Jan 2006 – 31 Dec 2006 | 112 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Henriette Wennicke | Current | |
| CEO | Per Emil Hasselbalch Stakemann | ||
| CEO | Jørgen Søberg Petersen | ||
| CEO | Mogens Ibenfeldt | ||
| CEO | Christian Grøndahl | ||
| CEO | John Hyttel | ||
| CEO | Mats Blom | ||
| CEO | Adam Sinding Steensberg | ||
| CEO | Matthew Donald Dallas | ||
| Board | Alf Gunnar Martin Nicklasson | Current | |
| Board | Kirsten Aarup Drejer | Current | |
| Board | Leonard Kruimer | Current | |
| Board | Anneline Nansen | Current | |
| Board | Ludovic Tranholm Otterbein | Current | |
| Board | Nikolaj Frederik Beck | Current | |
| Board | Adam Krisko Nygaard | Current | |
| Board | Tanja Lund Erichsen | Current | |
| Board | Katja Haaber Løje Hansen | Current | |
| Board | Lars Elmelund Pedersen | Current | |
| Board | Cecilie Kold | Current | |
| Board | Elaine Sullivan | Current | |
| Board | Enrique Alfredo Conterno Martinelli | Current | |
| Board | Iris Katharina Löw-Friedrich | Current | |
| Board | Camilla Sylvest | Current | |
| Board | Dan Buxbom | ||
| Board | Leif Helth Jensen | ||
| Board | Niels Erik Nielsen | ||
| Board | Jørgen Buus Lassen | ||
| Board | Leif Helth Jensen | ||
| Board | Leslie Lars Iversen | ||
| Board | Michael Thomas Sember | ||
| Board | Bent Benny Andersen | ||
| Board | Tom Larsen | ||
| Board | Gudmund Tyge Korsgaard | ||
| Board | Patrick John Paul Coleman | ||
| Board | Bo Lennart Bruce | ||
| Board | Ketil Jørgen Haugan | ||
| Board | Jan Honoré | ||
| Board | Lone Skjøttgaard Due | ||
| Board | Thierry Claude Laugel | ||
| Board | Lars Kolind | ||
| Board | Dr Alain Munoz | ||
| Board | Christian Thorkildsen | ||
| Board | Christian Thorkildsen | ||
| Board | Jean Christophe Renondin | ||
| Board | Rémi Droller | ||
| Board | Marlene Nørgaard Carolus | ||
| Board | Jesper Zeuthen | ||
| Board | Alain Munoz | ||
| Board | Linda Sjøstrøm | ||
| Board | Jens William Kindtler | ||
| Board | Christian Herskind Jørgensen | ||
| Board | Helle Størum | ||
| Board | Helle Størum | ||
| Board | Thomas Tscherning | ||
| Board | Anders Vadsholt | ||
| Board | Florian Nicolas Christian Reinaud | ||
| Board | Jutta Grevinde af Rosenborg | ||
| Board | James Peter Arthur Benson | ||
| Board | Hanne Heidenheim Bak | ||
| Board | Michael John Owen | ||
| Board | Jørgen Lindegaard | ||
| Board | Daniël Jan Ellens | ||
| Board | Søren Vitfell Keller | ||
| Board | Hanne Heidenheim Bak | ||
| Board | Jens Peter Stenvang | ||
| Board | Maria Juul Kolding | ||
| Board | Rosemary Crane | ||
| Board | Catherine Moukheibir | ||
| Board | Anne Kragh Sager | ||
| Board | Anneline Nansen | ||
| Board | Hanne Heidenheim Bak | ||
| Board | Helle Haxgart | ||
| Board | Helle Størum | ||
| Board | Christian Thorkildsen | ||
| Board | Rasmus Just | ||
| Board | Helle Haxgart | ||
| Board | Kirsten Aarup Drejer | ||
| Board | Jeffrey Berkowitz | ||
| Board | Bernadette Mary Connaughton | ||
| Board | Gertrud Koefoed Rasmussen | ||
| Board | Jacob Ulrik Fog | ||
| Board | Nikolaj Frederik Beck | ||
| Board | Iben Louise Gjelstrup | ||
| Owner (5%) | Polar Capital LLP | Current | |
| Owner (5%) | Avoro Life Sciences Fund LLC | Current | |
| Owner (0%) | Avoro Capital Advisors LLC | Current | |
| Owner (5%) | Van Herk Investments B.V. | Current | |
| Owner (0%) | Van Herk Management Services B.V. | Current | |
| Owner (5%) | ZEALAND PHARMA A/S | Current | |
| Owner (10%) | Innovation Capital | ||
| Owner (0%) | Innovation Capital | ||
| Owner (5%) | CDC Enterprises Capital Investissement | ||
| Owner (5%) | CDC Enterprises Capital Investissement | ||
| Owner (0%) | SUNSTONE CAPITAL A/S | ||
| Owner (5%) | SUNSTONE LIFE SCIENCE VENTURES FUND I K/S | ||
| Owner (5%) | K/S SUNSTONE BIOMEDICAL VENTURE ANNEX III | ||
| Owner (10%) | KAPITALFORENINGEN LD | ||
| Owner (5%) | CDC Enterprises Capital Investissement | ||
| Owner (0%) | Legg Mason, Inc. | ||
| Owner (0%) | SUNSTONE CAPITAL A/S | ||
| Owner (5%) | KAPITALFORENINGEN LD | ||
| Owner (0%) | SUNSTONE LIFE SCIENCE VENTURES A/S | ||
| Owner (0%) | SUNSTONE LIFE SCIENCE VENTURES A/S | ||
| Owner (5%) | Wellington Management Group LLP | ||
| Owner (15%) | Van Herk Investments B.V. | ||
| Owner (0%) | Van Herk Management Services B.V. | ||
| Owner (0%) | Wellington Management Group LLP | ||
| Owner (5%) | Wellington Management Group LLP | ||
| Owner (10%) | Van Herk Investments B.V. | ||
| Owner (0%) | Van Herk Management Services B.V. | ||
| Owner (10%) | Polar Capital LLP | ||
| Auditor | PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB | Current | |
| Auditor | ERNST & YOUNG DENMARK P/S | ||
| Auditor | H.E.H. 4 A/S | ||
| Auditor | DELOITTE STATSAUTORISERET REVISIONSAKTIESELSKAB | ||
| Auditor | Green IV ApS | ||
| Auditor | PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB | ||
| Auditor | DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB | ||
| Auditor | EY Godkendt Revisionspartnerselskab | ||
| Founder | VX 10.312 ApS | Current |
The CEOs' other companies
Henriette Wennicke – 3 other companies
- ZP GENERAL PARTNER 1 ApS Active
- ZP GENERAL PARTNER 2 ApS Active
- ZP General Partner 3 ApS Active
Per Emil Hasselbalch Stakemann – 45 other companies, of which 45 bankrupt
- "HEDEVANG MØBLER A/S" Bankrupt 27 Nov 1990
- "J.A.M. TRANSPORTBÅND A/S" Bankrupt 18 Aug 1993
- "NELLE'S RENGØRING A/S" Bankrupt 16 Jul 1990
- 'HG 405 PAVIA AF HIRTSHALS ApS' Bankrupt 4 Jul 2007
- 'ZOO-TEX ApS' Bankrupt 25 Nov 2016
- 02 HOLDING A/S Bankrupt 16 Oct 2008
- 09.28 ANNO 2007 ApS Bankrupt 13 Feb 2009
- 1/7 1987 A/S Bankrupt 21 Aug 2003
- 100 GB ApS Bankrupt 5 May 1994
- 11 DESIGN A/S Bankrupt 28 Apr 2015
- 1356 INVEST ApS Bankrupt 8 Apr 2011
- 15/11 1990 A/S Bankrupt 11 Oct 1994
- 15689382 ApS Bankrupt 26 Jun 2017
- 19.09.2021 ApS Bankrupt 8 Dec 2023
- 23/5 914 ApS Bankrupt 25 Jun 1991
- 3 X 65 SERVICE ApS Bankrupt 3 Mar 1997
- 3 X P A/S Bankrupt 10 Sep 1990
- 31.12.2007 X A/S Bankrupt 28 Oct 2008
- 3B DEVELOPMENT GROUP ApS Bankrupt 2 Nov 2006
- 4 FONTANE ApS Bankrupt 2 Oct 2002
- 4A MANAGEMENT ApS Bankrupt 7 May 1992
- 7 9 13 FORSIKRINGSERVICE ApS Bankrupt 20 Mar 2024
- A - INFORMATIK A/S Bankrupt 9 Oct 2013
- A J J FINANS NR. 1 ApS Bankrupt 23 Feb 1995
- A'SHARQ TV ApS Bankrupt 26 Nov 1992
- A-T SPECIALENTREPRICE ApS Bankrupt 3 Aug 2001
- A. K. OLIE ApS Bankrupt 18 Nov 2008
- A. UNO ApS Bankrupt 19 Jan 1996
- A.B. BYG ApS Bankrupt 4 Dec 1996
- A.H. GRAFIK ApS Bankrupt 23 Jan 1990
Jørgen Søberg Petersen – 10 other companies
- ACESION PHARMA ApS Active
- Allarity Therapeutics A/S Opløst
- Allarity Therapeutics Europe ApS Active
- Antag Therapeutics ApS Active
- BLUE Healthcare Investments ApS Opløst
- Breye Therapeutics ApS Active
- Hemab ApS Active
- INAGEN ApS Opløst
- RheumaLogics ApS Active
- mAbSolution IVS Opløst
Mogens Ibenfeldt – 3 other companies
- AKTIESELSKABET AF 20.NOVEMBER 2003 Active
- BETACURE HOLDING A/S Fusioneret
- ORIGIO A/S Active
Christian Grøndahl – 9 other companies
- Greendale Holding ApS Active
- PROMENADEN DRIFT ApS Opløst
- PROMENADEN HOLDING ApS Opløst
- SNIPR Biome ApS Active
- SNIPR Holdings ApS Active
- SeeQ Diagnostics ApS Active
- South Lake Holding ApS Active
- Troya Therapeutics ApS Active
- VITROLIFE A/S Active
John Hyttel – 1 other companies
- BETACURE HOLDING A/S Fusioneret
Adam Sinding Steensberg – 8 other companies
- Cas Capital ApS Active
- Cessatech A/S Active
- LEO Holding A/S Active
- Sil Capital ApS Active
- Vib Capital ApS Active
- ZP GENERAL PARTNER 1 ApS Active
- ZP GENERAL PARTNER 2 ApS Active
- ZP General Partner 3 ApS Active
Address history (2 moves)
| Sydmarken 11, 2860 Søborg | |
| Smedeland 36, 2600 Glostrup | |
| Smedeland 26B, 2600 Glostrup |
Former names
| ZEALAND PHARMA A/S | – now |
| ZEALAND PHARMACEUTICALS A/S | – |
| PEPTIDE PROBE TECHNOLOGIES ApS | – |
| ApS KBUS 8 NR. 4581 | – |
Employees per year
Other companies at the same address
- ZP GENERAL PARTNER 1 ApS Active
- ZP GENERAL PARTNER 2 ApS Active
- ZP General Partner 3 ApS Active
Similar companies in Gladsaxe
- PanTarg ApS Bagsværd
- CELCORE ApS Søborg
- BioCulture Nordic ApS Søborg
- NeXXerum ApS Søborg
- Sanos Holding A/S Søborg
- ZP General Partner 3 ApS Søborg
- CBio A/S Søborg
- Cellugy ApS Søborg
- Chromologics ApS Søborg
- L Folkersen Holding ApS Kongens Lyngby
- GlycoSpot ApS Søborg
- ZP GENERAL PARTNER 2 ApS Søborg
Questions and answers about ZEALAND PHARMA A/S
Has ZEALAND PHARMA A/S gone bankrupt?
No, ZEALAND PHARMA A/S is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of ZEALAND PHARMA A/S?
Our model estimates a bankruptcy risk of 0.4% over the next 12 months (low risk), which is 0.3 times the average for Danish companies.
Who is the CEO of ZEALAND PHARMA A/S?
Henriette Wennicke is the CEO of ZEALAND PHARMA A/S.
Who is the auditor of ZEALAND PHARMA A/S?
ZEALAND PHARMA A/S most recently used PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB.
When was ZEALAND PHARMA A/S founded?
ZEALAND PHARMA A/S was founded on 1 April 1997.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.